Serina Therapeutics, Inc.SERNYSE
LOADING
|||
EBITDA Over Time
Trending lower, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-10.49M
↓ 71% below average
Average (8y)
$-6.14M
Historical baseline
Range
High:$5.92M
Low:$-11.89M
CAGR
-1.6%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.49M | -277.2% |
| 2023 | $5.92M | +327.1% |
| 2022 | $-2.60M | -112.1% |
| 2021 | $-1.23M | +85.9% |
| 2020 | $-8.74M | +22.6% |
| 2019 | $-11.29M | -56.8% |
| 2018 | $-7.20M | +7.0% |
| 2017 | $-7.74M | +35.0% |
| 2016 | $-11.89M | - |